Checkmate 214 post hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma (ARCC) with sarcomatoid features (SRCC) Meeting Abstract


Authors: Grimm, M. O.; McDermott, D. F.; Choueiri, T. K.; Motzer, R. J.; Frontera, O. A.; George, S.; Powles, T.; Donskov, F.; Harrison, M. R.; Rodriguez-Cid, J.; Ishii, Y.; McHenry, B.; Rini, B. I.; Tannir, N. M.
Abstract Title: Checkmate 214 post hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma (ARCC) with sarcomatoid features (SRCC)
Meeting Title: 34. Deutscher Krebskongress (DKK)
Journal Title: Oncology Research and Treatment
Volume: 43
Issue: Suppl. 1
Meeting Dates: 2020 Feb 19-22
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2020-02-01
Start Page: 70
End Page: 71
Language: English
ACCESSION: WOS:000517158700172
PROVIDER: wos
DOI: 10.1159/000506491
Notes: "34th German Cancer Congress" -- Meeting Abstract: 132 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1248 Motzer